TNK2 TYROSINE KINASE AS A NOVEL THERAPEUTIC TARGET IN TRIPLE NEGATIVE BREAST CANCER
$221,034FY2015Department of the ArmyDOD
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc.
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc.